Medical Equipment

Cardiac Assist Devices And Equipment Market Overview 2026–2030 Highlighting Industry Developments

April 10, 2026April 10, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Cardiac Assist Devices And Equipment Market From 2026 To 2030?

The cardiac assist devices and equipment market size has shown substantial growth recently. This market is projected to expand from $2.35 billion in 2025 to $2.53 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.9%. The historical growth experienced by this sector is attributable to the increasing prevalence of advanced heart failure, the expansion of cardiac surgery programs, a rise in the use of mechanical circulatory support, improvements in implantable device design, and the growing availability of specialized cardiac care centers.

The cardiac assist devices and equipment market is projected to experience significant expansion in the coming years. This market is forecast to reach $3.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.4%. Factors contributing to this growth during the forecast period include a rise in demand for destination therapy devices, the increasing uptake of remote monitoring-enabled assist systems, the broadening of bridge-to-transplant applications, greater investments in advanced cardiac devices, and improvements in biocompatible materials and device miniaturization. Key trends anticipated over this period encompass the growing acceptance of implantable assist devices, an uptick in the utilization of minimally invasive cardiac support systems, the expanding integration of remote patient monitoring, the development of pediatric and specialized cardiac devices, and an intensified focus on the long-term reliability of these devices.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2401&type=smp

What Factors Are Contributing To The Growth Of The Cardiac Assist Devices And Equipment Market?

The growing occurrence of cardiovascular diseases (CVD) is boosting the need for cardiac assist devices and equipment across both developed and developing regions. The heightened requirement for identifying, overseeing, treating early, and preventing these fatal illnesses is further escalating the call for cardiac assist devices. For example, data from the American Heart Association, a non-profit organization situated in the US, indicates that by 2035, 45.1% of the US population is projected to be affected by some type of CVD. The overall expenses related to CVD are anticipated to hit $1.1 trillion by 2035, encompassing direct medical expenditures forecast at $748.7 billion and indirect costs estimated at $368 billion. Consequently, the increasing incidence of cardiovascular diseases is propelling the expansion of the cardiac assist devices and equipment market.

How Are Segments Identified Within The Cardiac Assist Devices And Equipment Market Segment Framework?

The cardiac assist devices and equipment market covered in this report is segmented –

1) By Type: Ventricular Assist Devices (LVAD), Intra-Aotic Baloon Pumps, Total Artificial Heart

2) By Modality: Transcutaneous, Implantable

3) By Application: Hospitals And Cardiac Care Centers, Ambulatory Surgical Centres, Emergency Services

Subsegments:

1) By Ventricular Assist Devices (LVAD): Implantable LVADs, Externally Powered LVADs, Pediatric LVADs, Other LVADs

2) By Intra-Aortic Balloon Pumps: Disposable Intra-Aortic Balloon Pumps, Reusable Intra-Aortic Balloon Pumps

3) By Total Artificial Heart: Pneumatically Powered Total Artificial Heart, Electrically Powered Total Artificial Heart, Other Total Artificial Heart Types

What Trends Are Shaping The Future Of The Cardiac Assist Devices And Equipment Market?

Leading companies within the cardiac assist devices and equipment market are prioritizing the development of miniaturized interventional ventricular assist devices (VADs), including foldable percutaneous VAD systems. These innovations aim to offer less-invasive circulatory support for patients undergoing high-risk percutaneous coronary interventions and those experiencing acute cardiogenic shock. A foldable percutaneous VAD system is a mechanical circulatory-support device delivered via catheter, engineered for insertion through a small arterial sheath to reduce vascular access size. It is designed to provide rapid left-ventricular unloading with clinically relevant flow rates and minimize procedural trauma when contrasted with larger surgical pumps. For example, in September 2023, magAssist, a China-based company specializing in circulatory-support devices, unveiled the NyokAssist interventional ventricular assist device. This device received U.S. FDA Breakthrough Device designation and successfully completed its initial human use. It functions as a small-bore (≈9 Fr) foldable catheter pump, incorporating an external motor to lower hemolysis risk, is designed for effortless delivery across the aortic arch, and achieved an average flow rate of >3 L/min during its reported first-in-human support for high-risk PCI.

Who Are The Companies Competing Within The Cardiac Assist Devices And Equipment Market?

Major companies operating in the cardiac assist devices and equipment market are Abbott Laboratories, Berlin Heart GmbH, Abiomed Inc., Bivacor Pvt. Ltd., Calon Cardio-Technology Ltd., Cardiobridge GmbH, Cardiac Assist Inc., Braile Biomedica Ltd., Circulite Inc., Evaheart Inc., FineHeart Sarl, Getinge AB, Jarvik Heart Inc., Medtronic plc, OregonHeart, MitiHeart Corporation, Procyrion Inc., Scandinavian Real Heart AB, Syncardia Systems LLC, HeartWare International Inc., Cardiac Power Innovations, Cardionomic Inc., Carmat SA, CorWave SA, Leviticus Cardio Ltd., LivaNova PLC, MicroMed Cardiovascular Inc., Novacor SA, Thoratec Corporation, Ventracor Limited

Get The Full Cardiac Assist Devices And Equipment Market Report:

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Which Region Holds The Highest Market Share In The Cardiac Assist Devices And Equipment Market?

North America was the largest region in global cardiac assist devices and equipment market in 2025. Western Europe was the second-largest region in cardiac assist devices and equipment market. The regions covered in the cardiac assist devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cardiac Assist Devices And Equipment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=2401&type=smp

Browse Through More Reports Similar to the Global Cardiac Assist Devices And Equipment Market 2026, By The Business Research Company

Bioinformatics Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioinformatics-global-market-report

Stem Cell Cord Blood Banking Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Analytical Laboratory Instrument Market Report 2026

https://www.thebusinessresearchcompany.com/report/analytical-laboratory-instrument-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795